When 'Try Naturally for a Year' Doesn't Apply to You

You have been told by friends, family, or your GP to wait the full year before getting checked out. You have been trying for four to eight months and something inside you is asking whether that rule actually fits your situation. It may not. The "year rule" was written as a default for couples with no known fertility factor, and every major guideline names exceptions where waiting is delay, not patience.

This post is the practical, loop-transitioning version of the patience-window pillar. If you are still in the first three months and feeling the cycle-three grief, the right reading is why most couples don't conceive in the first three months. If you are at four months or beyond and asking whether the year rule applies to you, this is the post that bridges from natural-cycle trying into evaluation and, often, into medication.

What the "year rule" actually says

The ASRM 2020 committee opinion on the definitions of infertility states the operating rule clearly: infertility evaluation is recommended after 12 months of unprotected, well-timed intercourse for couples in which the woman is under 35, six months for ages 35 to 39, and immediately for age 40+ or when there is a known fertility factor.¹ The same opinion notes that the 12-month threshold is the default for couples without risk factors, not a universal rule.

The NICE guideline NG73 in the UK uses similar thresholds and also names earlier referral criteria for known risk factors.⁵

The 12-month rule has a reasonable basis. The Gnoth time-to-pregnancy data show that 85 to 90 percent of couples without risk factors who eventually conceive will do so within 12 cycles.³ Waiting that long allows the natural cumulative pregnancy curve to play out before subjecting couples to investigations they may not need. But the same logic does not apply when a known factor is already present, and that is the part the casual "wait a year" advice usually skips.

Who should evaluate sooner: the official exceptions

The ASRM-named exceptions, broadly:

• Age 35 to 39: evaluate at six months.
• Age 40 or older: evaluate now, regardless of how long you have been trying.
• Known or suspected endometriosis.
• Prior pelvic surgery, prior ectopic pregnancy, prior chemotherapy, or prior pelvic radiation.
• Cycle irregularity meeting the 2023 PCOS Guideline anovulation criteria: cycles longer than 35 days, fewer than eight per year, or cycle-to-cycle variation greater than nine days.²
• Partner with known sperm-quality issues.
• Recurrent pregnancy loss (two or more clinical losses, per ASRM).

If any of these apply to you, the recommended pathway is not "keep waiting." It is "book the evaluation." The 12-month rule was never meant to apply to your situation, and the friends or family quoting it to you are usually drawing on a generic version they heard years ago.

Why PCOS specifically does not need to wait a year

The 2023 International Evidence-Based Guideline for PCOS is explicit on this point. For people with PCOS who are trying to conceive, evaluation and management should begin when conception has not occurred within six months of intentional trying with timed intercourse.² The Guideline frames this as a strong recommendation supported by the evidence base, not a soft suggestion.

There are two reasons for the six-month rule in PCOS, and both are worth understanding.

First, PCOS is itself a known fertility factor. The 12-month default applies to couples without known factors. PCOS-associated oligo-ovulation or anovulation is a known factor by definition, which moves you into the earlier-evaluation category.

Second, calendar months underestimate "tries" in PCOS. A person whose cycles run 50 days gets six to seven ovulatory attempts in 12 calendar months, compared with 13 attempts for someone on a 28-day cycle. Six PCOS months may correspond to three or four actual ovulatory chances. The clinical question is not "have you been trying for six months" but "have you had enough ovulatory cycles for the data to be informative," and in PCOS the answer arrives in fewer calendar months than the standard rule assumes.

Earlier evaluation does not mean immediate treatment. It means knowing what is happening so you can decide. A baseline evaluation in PCOS often reveals that everything else looks fine and ovulation induction with letrozole is the appropriate next step. I cover the long-cycle picture in long cycles with PCOS and the treatment side in letrozole for PCOS overview.

What "evaluation" actually means at the early visit

People often worry that an evaluation means committing to IVF. It does not. The first evaluation visit is mostly information-gathering, and almost none of it is invasive or expensive.

The standard ASRM workup for the female partner looks like this:⁴

• Cycle history: length, regularity, period characteristics, prior pregnancies, prior contraception, prior gynaecological history.
• Lab panel: AMH, FSH, LH, and oestradiol on cycle day two to five; TSH and prolactin; in PCOS, androgens (total testosterone, free testosterone, SHBG, DHEA-S).
• Pelvic ultrasound: antral follicle count, ovarian morphology (looking for the polycystic appearance), and screening for fibroids and polyps.
• Hysterosalpingogram (HSG): a dye study to check whether the fallopian tubes are open. This is often done early in evaluation because tubal disease is a major treatable cause of subfertility.

For the male partner, the ASRM workup recommends a semen analysis at first evaluation regardless of which partner is suspected of contributing.⁴ This is the single highest-yield test in the early workup, and it is non-invasive and inexpensive. I cover it in detail in semen analysis, what to expect.

The PCOS-specific workup adds antral follicle count and a more detailed metabolic panel. I cover this in PCOS workup essentials.

A semen analysis is not optional

I want to be specific about this one because it gets skipped more often than it should.

Approximately 40 to 50 percent of subfertility involves a male factor, often without symptoms.⁴ A man can have normal libido, normal erections, normal ejaculatory volume, and a semen analysis that shows low motility, low concentration, or abnormal morphology that meaningfully changes the per-cycle probability of conception. The only way to know is to test.

The test is straightforward: a single semen sample produced after two to seven days of abstinence, analysed for volume, sperm concentration, motility, morphology, and white blood cell count. Most clinics process the sample on-site. Results are usually available within a day or two.

ASRM is explicit that semen analysis should be part of the first evaluation, regardless of which partner is the presumed source of the difficulty.⁴ If your GP suggested an evaluation for you but not for your partner, that is worth pushing back on. The semen analysis is the most cost-effective single test in early fertility evaluation, and skipping it can mean months of unnecessary investigation in the partner with the female reproductive system.

What earlier evaluation does not mean

I name these explicitly because the anxiety of "going to a fertility doctor" often catastrophises what the visit actually is.

• It does not mean you immediately start IVF. IVF is the end of a long ladder, and the first visit is almost never the place where that ladder is entered.
• It does not mean you have a diagnosis of infertility. The clinical definition of infertility requires 12 months (or 6 months in named exceptions) of trying without conception. The early evaluation is gathering information, not assigning a diagnosis.
• It does not mean you are giving up on natural conception. Many early evaluations reveal nothing concerning, and the recommended next step is continuing natural-cycle trying with confirmed timing and confirmed ovulation.
• It does not mean you are wasting your clinician's time. The exceptions to the 12-month rule exist precisely so that couples in your situation are not stuck waiting through cycles that count as "data for the evaluation" rather than "chances to conceive."

What the typical decision tree looks like

After the workup, a small set of pathways covers most outcomes.

• Normal labs and normal semen analysis: continue natural-cycle trying with optimised timing for another three to six months. The evaluation has confirmed there is no identifiable issue, and the probability that the next several cycles will produce conception is reassuringly high.
• Anovulation or oligo-ovulation, especially in PCOS: ovulation induction is the next step. Letrozole is first-line for PCOS per the 2023 Guideline and the 2014 PALO trial; clomiphene is second-line.²
• Male-factor issue: the conversation moves to IUI or, depending on parameters, IVF.
• Tubal blockage on HSG: IVF is usually the recommended pathway, because IUI requires patent tubes.
• Diminished ovarian reserve (low AMH, high FSH): a faster move to IVF is often discussed, because the calendar window for ovarian response is narrowing.

I cover the next steps in letrozole for PCOS overview, IUI overview, and when to consider IVF.

What to say to your clinician

If you are reaching out to your GP or primary-care provider for a referral, the most efficient phrasing is to name the specific exception that applies and ask directly.

For example: "I have PCOS with cycles averaging 45 days and I have been trying to conceive for six months. The 2023 PCOS Guideline recommends evaluation at six months in PCOS. Can you refer me to a reproductive endocrinologist?"

Or: "I am 36 and have been trying for six months. ASRM recommends evaluation at six months for ages 35 to 39. I would like a referral for fertility evaluation."

If your primary-care provider says "keep trying for another six months," you can request the referral directly. In the US, you do not need primary-care approval to see a reproductive endocrinologist if you are willing to pay out of pocket; insurance coverage varies. In the UK, NHS pathways vary by region, and self-referral to NHS fertility services is generally not available, but the GP referral pathway should follow NICE guidance.⁵

Bring a cycle log of at least three to six cycles to the visit. The pattern across cycles is the most useful information your clinician can have.

The emotional reality of "going in early"

Many couples feel guilty or premature about seeking evaluation before the year mark. I want to name that and address it directly.

You are not failing at TTC by gathering data earlier. The exceptions to the year rule exist precisely because waiting longer in named situations costs you cycles without producing useful information. Knowing your numbers reduces the emotional cost of the months ahead, because the question shifts from "is something wrong" to "this is what we know."

An evaluation that finds nothing wrong is itself useful. It moves you from "what if there is a hidden issue" to "this is normal probability and the next cycles have meaningful odds." That shift is worth more than another three months of uncertainty.

If your evaluation reveals an issue, the early discovery is also useful. Letrozole on cycle four is better than letrozole on cycle 14, both biologically and emotionally.

What is normal, what is a flag

Normal: most couples without exceptions do conceive within 12 cycles, and the year rule fits them well.

Worth discussing: any of the official exceptions above. PCOS, age 35+, known fertility factors, prior surgery, recurrent loss, or partner sperm-quality concerns all shift the recommendation.

Red flag: bleeding so heavy it requires changing pads every hour, severe pelvic pain, suspicion of ectopic, or no period for 90+ days outside pregnancy. These are not "wait and see" situations.

What you can do tonight

1. Look at the exception list above and decide honestly whether any apply to you. PCOS, age 35+, known endometriosis, prior surgery, partner with sperm-quality issues, recurrent loss.
2. If yes: book the evaluation appointment this week. Do not wait for the next cycle to fail.
3. If no but you are at six or more months of trying and worried: a consult is still reasonable. You are not "wasting their time."
4. Pull together your cycle log for the visit. Three to six cycles of dates, OPK results, BBT shifts, and bleed patterns is the right starting set.
5. If you have a partner, this is the right week to talk about the evaluation visit together. The semen analysis is part of the workup, and aligning on that conversation before the appointment is easier than after.

What's next

• If you are still in the early-window mindset: why most couples don't conceive in the first three months
• For the PCOS-specific cycle picture: long cycles with PCOS
• For what the workup contains: PCOS workup essentials and semen analysis, what to expect
• For finding the right specialist: finding an RE
• For the most common next-step treatment: letrozole for PCOS overview

Sources

1. Practice Committee of the American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertility and Sterility 2020;113(3):533-535. https://doi.org/10.1016/j.fertnstert.2019.11.025
2. Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 International Evidence-Based Guideline for the Assessment and Management of Polycystic Ovary Syndrome. Fertility and Sterility 2023;120(4):767-793. https://doi.org/10.1016/j.fertnstert.2023.07.025
3. Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile female: a committee opinion. Fertility and Sterility 2015;103(6):e44-e50. https://doi.org/10.1016/j.fertnstert.2015.03.019
4. Practice Committee of the American Society for Reproductive Medicine. Diagnostic evaluation of the infertile male: a committee opinion. Fertility and Sterility 2015;103(3):e18-e25. https://doi.org/10.1016/j.fertnstert.2014.12.103
5. National Institute for Health and Care Excellence. Fertility problems: assessment and treatment. NICE guideline NG73. London: NICE; 2017 (updated 2024). https://www.nice.org.uk/guidance/cg156